BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16610311)

  • 21. [The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease].
    Soyyiğit S; Erk M; Güler N; Kilinç G
    Tuberk Toraks; 2006; 54(3):259-66. PubMed ID: 17001544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mid-term effects of lung volume reduction surgery on pulmonary function in patients with chronic obstructive pulmonary disease.
    Liu JM; Yang WL; Jiang GN; Ding JA; Zheng W; Liu WZ; Wang YM; Gao BL; Jiang P; Wu W; Li X; Bjorn J
    Chin Med J (Engl); 2007 Apr; 120(8):658-62. PubMed ID: 17517180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Native lung volume reduction surgery relieves functional graft compression after single-lung transplantation for chronic obstructive pulmonary disease.
    Reece TB; Mitchell JD; Zamora MR; Fullerton DA; Cleveland JC; Pomerantz M; Lyu DM; Grover FL; Weyant MJ
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):931-7. PubMed ID: 18374782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoventilation in asthma and chronic obstructive pulmonary disease.
    Beuther DA
    Semin Respir Crit Care Med; 2009 Jun; 30(3):321-9. PubMed ID: 19452392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of a pulmonary rehabilitation programme on older patients with chronic pulmonary disease.
    Kyung KA; Chin PA
    J Clin Nurs; 2008 Jan; 17(1):118-25. PubMed ID: 17394540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary function in patients with focal pulmonary tuberculosis].
    Nefedov VB; Popova LA; Shergina EA
    Probl Tuberk Bolezn Legk; 2008; (3):23-6. PubMed ID: 18450075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor interpretation of pulmonary function tests in patients with concomitant decreases in FEV1 and FVC.
    Hong Y; Ra SW; Shim TS; Lim CM; Koh Y; Lee SD; Kim WS; Kim DS; Kim WD; Oh YM
    Respirology; 2008 Jun; 13(4):569-74. PubMed ID: 18410263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clara cell 16 protein in COPD sputum: a marker of small airways damage?
    Braido F; Riccio AM; Guerra L; Gamalero C; Zolezzi A; Tarantini F; De Giovanni B; Folli C; Descalzi D; Canonica GW
    Respir Med; 2007 Oct; 101(10):2119-24. PubMed ID: 17624750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
    Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
    Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.
    Montes de Oca M; Tálamo C; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
    Respir Med; 2008 May; 102(5):642-50. PubMed ID: 18314321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new ATS/ERS guidelines for assessing the spirometric severity of restrictive lung disease differ from previous standards.
    Aggarwal AN; Agarwal R
    Respirology; 2007 Sep; 12(5):759-62. PubMed ID: 17875068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2007 GOLD Guidelines: a comprehensive care framework.
    Gold PM
    Respir Care; 2009 Aug; 54(8):1040-9. PubMed ID: 19650945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.
    Johnston AK; Mannino DM; Hagan GW; Davis KJ; Kiri VA
    Thorax; 2008 Jul; 63(7):599-605. PubMed ID: 18245145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic obstructive pulmonary disease: diagnosis and management.
    Downs CA; Appel SJ
    J Am Acad Nurse Pract; 2007 Mar; 19(3):126-32. PubMed ID: 17341279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the new ATS/ERS pulmonary function test interpretation guidelines.
    Kreider ME; Grippi MA
    Respir Med; 2007 Nov; 101(11):2336-42. PubMed ID: 17686622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [World-wide initiative against chronic obstructive bronchitis. GOLD (Global Initiative for Chronic Obstructive Lung Disease) should save lungs].
    Fath R
    MMW Fortschr Med; 2002 Jan; 144(1-2):14. PubMed ID: 11847875
    [No Abstract]   [Full Text] [Related]  

  • 38. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.
    Swanney MP; Ruppel G; Enright PL; Pedersen OF; Crapo RO; Miller MR; Jensen RL; Falaschetti E; Schouten JP; Hankinson JL; Stocks J; Quanjer PH
    Thorax; 2008 Dec; 63(12):1046-51. PubMed ID: 18786983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease--a population-based study.
    Ekberg-Aronsson M; Löfdahl K; Nilsson JA; Löfdahl CG; Nilsson PM
    Respir Med; 2008 Jan; 102(1):109-20. PubMed ID: 17928213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
    Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.